NCT07523152Not yet recruiting
Assessment of Sexual Quality of Life Following Local Treatment (Radiotherapy With or Without Surgery) in Patients With HPV-positive Pelvic Cancer: a Descriptive Longitudinal Study
Source: ClinicalTrials.gov · Last updated 13 Apr 2026
Brief summary (registry, in English)
In patients with cancer associated with human papillomavirus (HPV), the physical effects of treatment, combined with the psychosexual impact linked to HPV status, can further impair the quality of sexual life. However, few studies have examined the specific effect of HPV status (or knowledge of status) on the recovery/quality of sexuality following radiotherapy. It is against this backdrop that we propose a prospective longitudinal study specifically dedicated to investigating the sexual quality of life of women with HPV-positive pelvic cancer. This type of study will enable better quantification and description of sexual dysfunction occurring after treatment, and assessment of the impact of HPV carriage, with the future aim of guiding new prevention and management strategies.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 42 (estimated)
- First submitted
- 4 Apr 2026
- Start date
- 2 Apr 2026
- Primary completion date
- 31 Oct 2027
- Lead sponsor
- Institut du Cancer de Montpellier - Val d'Aurelle
- NCT number
- NCT07523152
What you commit to
- Study type: Interventional
- Planned participants: 42
- From 2 Apr 2026 to the primary completion date, 31 Oct 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients receiving radiotherapy treatment outside the Montpellier Cancer Institute (ICM).
Other
- Patients who are unwilling or unable to complete the study questionnaires.
- Patients under guardianship, curatorship or court protection,
- Patients for whom regular follow-up is impossible for psychological reasons,
- Patients who do not speak French.
Who the study is looking for
- Women aged 18 or over.
- Sexually active patients, i.e. those who have been sexually active in the year prior to their cancer diagnosis.
- Patients being treated at the Montpellier Cancer Institute (ICM).
- Patient with pelvic squamous cell carcinoma (cervix, vagina, vulva or anus) and human papillomavirus (HPV+) infection
- Patient aware of her HPV status and how it is transmitted.
- Indicated for external radiotherapy
- Patient who has not received any oncological treatment prior to inclusion.
- Patient who has given verbal consent.
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.